Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 7.73155 | 93 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 7.71734 | 92 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 7.71408 | 92 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 7.23199 | 89 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 7.40531 | 91 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 7.58575 | 93 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 7.83714 | 94 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 7.42874 | 91 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 7.2969 | 91 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 7.55519 | 92 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 7.73457 | 93 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 7.65056 | 92 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 7.59615 | 92 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 7.61581 | 92 |